Answers are grounded in this paper and cite their sources.
Genome-wide association studies identify Alzheimer’s disease (AD) susceptibility genes, but understanding how these genetic signals are organized across ageing, disease progression and cell types is a fundamental biological challenge. We developed single-cell Genetically Informed Perturbation Analysis (scGIPA) to integrate AD associations, brain regulatory evidence and hippocampal single-nucleus transcriptomes, resolving cellular contributions and genetic-route dependence through in silico perturbation. Across healthy ageing and early and later pathology, six overlapping functional modules showed stage-dependent cellular configurations; lipid-clearance and amyloid-fibril-regulation contributions peaked in early pathology. Of 1,469 AD-associated genes, 349 contributed to both ageing and pathology, representing 50.2% of participating genes. Genes contributing to both ageing and pathology preferentially retained contributions in the same cell types and were enriched in an external microglial co-expression module. PVR and HBEGF highlighted endothelial ageing, whereas APOE and BIN1 showed changing cellular contributions and genetic-route dependence across stages. Our findings reveal how AD susceptibility is reorganized across ageing and pathology within interconnected vascular, glial and neuronal programmes.
No takes yet. Share an insight, caveat, or question.
Meng et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: